Abstract
Phase Ib trial of superoxide (SO) dismutase (SOD) mimetic GC4419 to reduce chemoradiotherapy (CRT)-induced oral mucositis (OM) in patients (pts) with oral cavity or oropharyngeal carcinoma (OCC)
Journal of clinical oncology, v 34(15_suppl), pp 10120-10120
20 May 2016
Abstract
Abstract only
Metrics
13 Record Views
Details
- Title
- Phase Ib trial of superoxide (SO) dismutase (SOD) mimetic GC4419 to reduce chemoradiotherapy (CRT)-induced oral mucositis (OM) in patients (pts) with oral cavity or oropharyngeal carcinoma (OCC)
- Creators
- Carryn M. Anderson - University of Iowa Hospitals and ClinicsBryan G. Allen - University of Iowa Hospitals and ClinicsWenqing Sun - University of Iowa Hospitals and ClinicsSanjiv S. Agarwala - St. Luke's HospitalChristopher M. Lee - Cancer Care NorthwestMadhavi L. Venigalla - Lakeland Regional Medical CenterLarisa Greenberg - Allegheny General HospitalDouglas Adkins - Washington University in St. LouisYuhchyau Chen - University of Rochester Medical CenterWeining Zhen - University of Nebraska Medical CenterDiane R. Mould - Phoenixville HospitalJon Holmlund - Galera Therapeutics, Inc, Malvern, PAJeffrey Mark Brill - Galera Therapeutics, Inc, Malvern, PAStephen T. Sonis - BioModels, Boston, MAJohn Michael Buatti - University of Iowa Hospitals and Clinics
- Publication Details
- Journal of clinical oncology, v 34(15_suppl), pp 10120-10120
- Publisher
- AMER SOC CLINICAL ONCOLOGY; ALEXANDRIA
- Number of pages
- 1
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- General Internal Medicine
- Web of Science ID
- WOS:000404712500108
- Other Identifier
- 991021930838704721
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Web of Science research areas
- Oncology